Cancer Institute Hospital of JFCR
New Treatment For Melanoma Approved! 61.3% Efficacy Rate!
Ovarian Cancer Heavyweight Cutting-Edge ADC Drug Elahere Proven Safe And Effective
New Study Reveals Antibiotic Abuse For Sore Throats Pushes Up The Third Leading Cause Of Death Worldwide
Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China
Swimming is the most effective exercise for longevity
